Korsana Biosciences, Inc. (KRSA)
NASDAQ · Manufacturing · Pharmaceutical preparations
$31.00−$6.19 (−16.64%) on the dayAs of the close; data may be delayed.
KRSA price, last 12 months
Key stats
- Previous close
- $37.19
- Open
- $37.19
- Day range
- $30.59 – $37.25
- 52-week range
- $21.00 – $37.27
- Volume
- 30.4K
- Avg volume (20 days)
- —
- Market cap
- $1.4B
Performance
1W−11.4%
1M—
3M—
6M—
YTD—
1Y—
About Korsana Biosciences, Inc.
Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.4B